- 公司信息
- 药品资讯网－－－新药研发行业门户，新药研发企业首选信息网站！
- 免费注册
- ,(2S)-N-(2-chloro-2-cyclohexen-1-yl)-2-(1,3-dioxo-
- ,methyl 1-[(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoind
- ,(2R)-2-bromo-3-phenylpropanoic acid
- ,benzhydryl (4S,7S,12bR)-7-{[(2R)-2-bromo-3-phenyl
- ,2,6-piperidinedicarbonitrile
- ,1-[(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl
- ,(7S)-7-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-6
- ,(7S)-7-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-6
- ,pentanedial
- ,(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3
- ,2-{(1S)-1-benzyl-2-oxo-2-[1(4H)-pyridinyl]ethyl}-
- ,(4S,7S,12bR)-7-amino-6-oxo-1,2,3,4,6,7,8,12b-octa
- ,(4S,7S,12bR)-7-{[(2R)-2-bromo-3-phenylpropanoyl]a
- ,N-[(1R)-1-formyl-2-(4-hydroxyphenyl)ethyl]-N-meth
- ,methyl (2R)-2-[((2R)-3-(4-hydroxyphenyl)-2-{methy
- ,methyl (2R)-3-(4-methoxyphenyl)-2-((3S)-3-{methyl
- ,methyl (2R)-2-{(3S)-3-[(tert-butoxycarbonyl)(meth
- ,methyl (2R)-2-{(3S)-3-[(tert-butoxycarbonyl)(meth
- ,methyl (2R)-2-{(3S)-3-[(tert-butoxycarbonyl)(meth
- ,tert-butyl (3S)-8-hydroxy-1-[(1R)-2-hydroxy-1-(4-
- ,tert-butyl (3S)-8-hydroxy-1-[(1R)-2-hydroxy-1-(4-
- ,tert-butyl (3S)-1-[(1R)-1-formyl-2-(4-methoxyphen
- ,tert-butyl (1S,3S)-7-hydroxy-6-(4-methoxybenzyl)-
- ,tert-butyl (1S,3S)-7,9-dihydroxy-6-(4-methoxybenz
- 1623-08-1,Dibenzyl phosphate; Phosphoric acid dibe
- ,tert-butyl (1S,3S)-9-{[bis(benzyloxy)phosphoryl]o
- 50-85-1,2-Hydroxy-4-methylbenzoic acid; 2-Hydroxy-
- ,ethyl 2-ethoxy-4-methylbenzoate
- ,ethyl 4-(bromomethyl)-2-ethoxybenzoate
- ,ethyl 4-(cyanomethyl)-2-ethoxybenzoate
- ,ethyl 2-ethoxy-4-(2-ethoxy-2-oxoethyl)benzoate
- 81-64-1,1,4-Dihydroxy-9,10-anthracenedione; 1,4-Di
- NAPROXEN SODIUM,TABLET; ORAL,EQ 250MG BASE
- NAPROXEN SODIUM,TABLET; ORAL,EQ 500MG BASE
- LORAZEPAM,INJECTABLE; INJECTION,2MG/ML
- LORAZEPAM,INJECTABLE; INJECTION,4MG/ML
- GLIPIZIDE,TABLET; ORAL,5MG
- GLIPIZIDE,TABLET; ORAL,10MG
- INDAPAMIDE,TABLET; ORAL,2.5MG
- INDAPAMIDE,TABLET; ORAL,1.25MG
- ATENOLOL,TABLET; ORAL,25MG
- MINOXIDIL (FOR MEN),SOLUTION; TOPICAL,2%
- NADOLOL,TABLET; ORAL,20MG
- NADOLOL,TABLET; ORAL,40MG
- NADOLOL,TABLET; ORAL,80MG
- ISOFLURANE,LIQUID; INHALATION,99.9%
- TAMOXIFEN CITRATE,TABLET; ORAL,EQ 10MG BASE
- TAMOXIFEN CITRATE,TABLET; ORAL,EQ 20MG BASE
- CAPTOPRIL,TABLET; ORAL,12.5MG
- CAPTOPRIL,TABLET; ORAL,25MG
- CAPTOPRIL,TABLET; ORAL,50MG
- CAPTOPRIL,TABLET; ORAL,100MG
- CIMETIDINE,TABLET; ORAL,200MG
- CIMETIDINE,TABLET; ORAL,300MG
- CIMETIDINE,TABLET; ORAL,400MG
- CIMETIDINE,TABLET; ORAL,800MG
- NICOTINE POLACRILEX,GUM, CHEWING; BUCCAL,EQ 2MG BA
- AMANTADINE HYDROCHLORIDE,SYRUP; ORAL,50MG/5ML
- ETOPOSIDE,INJECTABLE; INJECTION,20MG/ML
- SULSTER,SOLUTION/DROPS; OPHTHALMIC,EQ 0.23% PHOSPH
- CLEMASTINE FUMARATE,TABLET; ORAL,1.34MG
- ETOPOSIDE,INJECTABLE; INJECTION,20MG/ML
- DICLOFENAC SODIUM,TABLET, DELAYED RELEASE; ORAL,50
- DICLOFENAC SODIUM,TABLET, DELAYED RELEASE; ORAL,75
- 行业分类
- 药品资讯网－－－新药研发行业门户，新药研发企业首选信息网站！
- 发布信息
